|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 114, Issue 5 1019-1024, Copyright © 2001 by Company of Biologists
JOURNAL ARTICLES |
ZA Abdel-Malek, MC Scott, M Furumura, ML Lamoreux, M Ollmann, GS Barsh and VJ Hearing
Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. abdelmza@email.uc.edu
The agouti gene codes for agouti signaling protein (ASP), which is temporally expressed in wild-type mouse follicular melanocytes where it induces pheomelanin synthesis. Studies using purified full-length agouti signaling protein has shown that it competes with (&agr;)-melanocyte stimulating hormone for binding to the melanocortin 1 receptor. We have investigated whether ASP binds exclusively to the melanocortin 1 receptor expressed on mouse melanocytes in primary culture, or additionally activates a receptor that has not been identified yet. We have compared the responses of congenic mouse melanocytes derived from C57 BL/6J-E(+)/E(+), e/e, or E(so)/E(so) mice to (alpha)-MSH and/or ASP. E(+)/E(+) melanocytes express the wild-type melanocortin 1 receptor, e/e melanocytes express a loss-of-function mutation in the melanocortin 1 receptor that results in a yellow coat color, and E(so)/E(so) is a mutation that causes constitutive activation of the melanocortin 1 receptor and renders melanocytes unresponsive to (alpha)-melanocyte stimulating hormone. Mouse E(+)/E(+) melanocytes, but not e/e or E(so)/E(so) melanocytes, respond to agouti signaling protein with decreased basal tyrosinase activity, and reduction in levels of tyrosinase and tyrosinase-related proteins 1 and 2. Only in E(+)/E(+) melanocytes does agouti signaling protein abrogate the stimulatory effects of (alpha)-melanocyte stimulating hormone on cAMP formation and tyrosinase activity. These results indicate that a functional melanocortin 1 receptor is obligatory for the response of mammalian melanocytes to agouti signaling protein.
This article has been cited by other articles:
|
|
 |
|
  G. Diwakar, D. Zhang, S. Jiang, and T. J. Hornyak Neurofibromin as a regulator of melanocyte development and differentiation J. Cell Sci., January 15, 2008; 121(2): 167 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Czyzyk, M. A. Sikorski, L. Yang, and G. S. McKnight Disruption of the RII subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice PNAS, January 8, 2008; 105(1): 276 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Getting, C. W. Lam, A. S. Chen, P. Grieco, and M. Perretti Melanocortin 3 receptors control crystal-induced inflammation FASEB J, November 1, 2006; 20(13): 2234 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li, D.-N. Hu, H. Zhao, S. A. McCormick, J. J. Nordlund, and R. E. Boissy Uveal Melanocytes Do Not Respond To or Express Receptors for {alpha}-Melanocyte-Stimulating Hormone. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4507 - 4512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Getting, H. C. Christian, C. W. Lam, F. N. E. Gavins, R. J. Flower, H. B. Schioth, and M. Perretti Redundancy of a Functional Melanocortin 1 Receptor in the Anti-inflammatory Actions of Melanocortin Peptides: Studies in the Recessive Yellow (e/e) Mouse Suggest an Important Role for Melanocortin 3 Receptor J. Immunol., March 15, 2003; 170(6): 3323 - 3330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Scott, K. Wakamatsu, S. Ito, A. L. Kadekaro, N. Kobayashi, J. Groden, R. Kavanagh, T. Takakuwa, V. Virador, V. J. Hearing, et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation J. Cell Sci., January 6, 2002; 115(11): 2349 - 2355. [Abstract] [Full Text] [PDF]
|
|
